A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease

Respiratory Medicine

Volumn 107, Issue 9, 2013, Pages 1385-1392

  Donath, Elie ^a   Chaudhry, Abubakr ^a   Hernandez Aya, Leonel F ^b   Lit, Louis ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antibiotic prophylaxis; Chronic Obstructive; COPD exacerbation; Macrolides; Meta analysis; Pulmonary Disease

Indexed keywords

MACROLIDE; PLACEBO;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS; DISEASE EXACERBATION; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SENSITIVITY ANALYSIS; SMOKING;

ANTIBIOTIC PROPHYLAXIS; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COPD; COPD EXACERBATION; INTENTION-TO-TREAT; ITT; MACROLIDES; META-ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RCT;

AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; MACROLIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84883052698     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.05.004     Document Type: Article

References (19)

1. J.M. Anto, P. Vermeire, and J. Vestbo Epidemiology of chronic obstructive pulmonary disease Eur Respir J 17 2001 982 994
2. P. Black, T. Staykova, E. Chacko, F.S. Ram, and P. Poole Prophylactic antibiotic therapy for chronic bronchitis Cochrane Database Syst Rev 1 2003 CD004105
3. J. Altenburg, C. de Graaf, and Y. Stienstra Effect of azithromycin maintenance treatment of infectious exacerbations among patients with non-cystic fibrosis bronchiectasis J Am Med Assoc 309 12 2013 1251 1259
4. K.W. Southern, P.M. Barker, and A. Solis Macrolide antibiotics for cystic fibrosis Cochrane Database Syst Rev 2 2004 CD002203
5. M. Yamaya, A. Azuma, H. Takizawa, J. Kadota, J. Tamaoki, and S. Kudoh Macrolide effects on the prevention of CODP exacerbations Eur Respir J 40 2 2012 485 494
6. R. Albert, J. Connett, and W. Bailey Azithromycin for prevention of exacerbations of COPD New Engl J Med 365 8 2011 689 698
7. D. Banerjee, O.A. Khair, and D. Honeybourne The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD Respir Med 99 2005 208 215
8. T. Seemungal, T. Wilkinson, J. Hurst, W. Perera, R. Sapsford, and J. Wedzicha Long-term erythromycin therapy is associated with decreased chronic COPD exacerbations Am J Respir Crit Care Med 178 2008 1139 1147
9. F. Blasi, D. Bonardi, and S. Aliberti Long-term azithromycin use in patients with COPD and tracheostomy Pulm Pharmacol Ther 23 2010 200 207
10. Z. He, L. Ou, and J. Zhang Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in COPD Respiration 80 2010 445 452
11. T. Suzuki, M. Yanai, and M. Yamaya Erythromycin and common cold in COPD Chest 120 2001 730 733
12. E. Wouters, K. Groenewegen, M. Dentener, and J. Vernooy Systemic inflammation in chronic obstructive pulmonary disease Proc Am Thorac Soc 4 8 2007 626 634
13. R. Dumke, H. von Baum, P.C. Lück, and E. Jacobs Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany Clin Microbiol Infect 16 2009 613 616
14. M. Morozumi, S. Iwata, and K. Hasegawa Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community acquired pneumonia Antimicrobial Agents Chemother 52 2008 348 350
15. M. Yamaya, A. Azuma, and H. Tanaka Inhibitory effects of macrolides on exacerbations and hospitalization in COPD in Japan: a retrospective multicenter analysis J Am Geriatr Soc 56 2008 1358 1360
16. J. Gomez, V. Banos, and E. Simarro Prospective comparative study (1994-1998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD Rev Esp Quimioter 13 2000 379 383
17. A. Lindberg, A.C. Jonsson, E. Ronmark, R. Lundgren, L. Larsson, and B. Lundback Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort Chest 127 5 2005 1544 1552
18. R. de Marco, S. Accordini, and I. Cerveri An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages Thorax 59 2 2004 120 125
19. W. Ray, K. Murray, K. Hall, P. Arbogast, and C. Stein Azithromycin and the risk of cardiovascular death New Engl J Med 366 20 2012 1881 1890